These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27211355)

  • 1. [Problem solving care models for Parkinson's disease].
    Csóka M; Molnár S; Kellős É; Domján G
    Orv Hetil; 2016 May; 157(22):855-68. PubMed ID: 27211355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches].
    Faludi B; Janszky J; Komoly S; Kovács N
    Orv Hetil; 2015 Jul; 156(27):1091-9. PubMed ID: 26122904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor fluctuations in Parkinson's disease.
    Crabb L
    Prof Nurse; 2000 Jan; 15(4):273-7. PubMed ID: 10983145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Parkinson's disease medication protocol program on nurses' knowledge and management of Parkinson's disease medicines in acute and aged care settings.
    Chenoweth L; Sheriff J; McAnally L; Tait F
    Nurse Educ Today; 2013 May; 33(5):458-64. PubMed ID: 22626862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sleep disturbances in Parkinson's disease].
    Boczarska-Jedynak M; Opala G
    Neurol Neurochir Pol; 2005; 39(5):380-8. PubMed ID: 16273462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic management of Parkinson's disease in long-term care residents: maintaining functionality to improve quality of life.
    Silver DE
    Director; 2007; 15(2):20-9. PubMed ID: 19343903
    [No Abstract]   [Full Text] [Related]  

  • 7. Parkinson's disease, palliative care and older people: Part 2.
    Thomas S; MacMahon D
    Nurs Older People; 2004 Apr; 16(2):22-6; quiz 28. PubMed ID: 15119154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Falls in Parkinson's disease. Causes and impact on patients' quality of life.
    Michałowska M; Fiszer U; Krygowska-Wajs A; Owczarek K
    Funct Neurol; 2005; 20(4):163-8. PubMed ID: 16483454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden.
    Midlöv P; Bondesson A; Eriksson T; Petersson J; Minthon L; Höglund P
    Eur J Clin Pharmacol; 2002 Feb; 57(12):903-10. PubMed ID: 11936711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young-onset Parkinson's disease: a guide to care and support.
    McCall B
    Nurs Times; 2003 Jul 29-Aug 4; 99(30):28-31. PubMed ID: 12961940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoiding mental changes and falls in older Parkinson's patients.
    Paulson GW; Schafer K; Hallum B
    Geriatrics; 1986 Aug; 41(8):59-62, 67. PubMed ID: 3732809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on Parkinson's: causes, treatment and support.
    Heisters D
    Br J Community Nurs; 2011 Apr; 16(4):182-3. PubMed ID: 21471920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rivastigmine as adjunctive therapy in the therapeutic dilemma for the treatment of hallucinations due to Parkinson disease].
    Rovers JM; Dautzenberg PL; ter Bruggen JP
    Tijdschr Gerontol Geriatr; 2006 Jul; 37(3):117-20. PubMed ID: 16886519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising medication for Parkinson's disease patients with dysphagia.
    Patel K
    Br J Community Nurs; 2015 Jul; 20(7):322, 324-6. PubMed ID: 26140316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of medications for Parkinson's disease: a qualitative description.
    Shin JY; Habermann B
    J Clin Nurs; 2016 Jan; 25(1-2):127-33. PubMed ID: 26420046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of deep brain stimulation in our patients with Parkinson's disease].
    Tamás G; Takáts A; Radics P; Rózsa I; Csibri E; Rudas G; Golopencza P; Entz L; Fabó D; Eross L
    Ideggyogy Sz; 2013 Mar; 66(3-4):115-20. PubMed ID: 23750427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
    Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M
    No To Shinkei; 2004 Apr; 56(4):351-4. PubMed ID: 15237728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.